| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3924 |
| Trial ID | NCT06481228 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Co-treatment | Venetoclax|Olverembatinib |
| Phase | Not Applicable |
| Recruitment status | Not Recruiting |
| Title | Efficacy and Safety of Molecular Targeted Therapy Combined With Chemotherapy and Sequential CAR-T Cells in Newly Diagnosed Adult Patients With Philadelphia Chromosome-Positive B-cell Acute Lymphoblastic Leukemia |
| Year | 2024 |
| Country | China |
| Company sponsor | Institute of Hematology & Blood Diseases Hospital, China |
| Other ID(s) | IIT2024019 |
| Cohort 1 | |||||||||
|
|||||||||